Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection. [electronic resource]
Producer: 20210624Description: 232-240 p. digitalISSN:- 1878-3503
- Antiviral Agents -- therapeutic use
- Carbamates
- Coinfection -- drug therapy
- Drug Therapy, Combination
- Genotype
- HIV Infections -- complications
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles
- Liver Cirrhosis -- complications
- Prospective Studies
- Pyrrolidines
- Ribavirin -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sustained Virologic Response
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.